DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ABITREXATE

« Back to Dashboard

All Clinical Trials for Abitrexate

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00003702	Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia	Completed	Eastern Cooperative Oncology Group	Phase 3	1999-06-01	Randomized phase III trial to compare the effectiveness of methotrexate with that of dactinomycin in treating patients who have gestational trophoblastic neoplasia. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether methotrexate is more effective than dactinomycin in treating patients with gestational trophoblastic neoplasia.
NCT00003702	Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia	Completed	National Cancer Institute (NCI)	Phase 3	1999-06-01	Randomized phase III trial to compare the effectiveness of methotrexate with that of dactinomycin in treating patients who have gestational trophoblastic neoplasia. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether methotrexate is more effective than dactinomycin in treating patients with gestational trophoblastic neoplasia.
NCT00003702	Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia	Completed	Gynecologic Oncology Group	Phase 3	1999-06-01	Randomized phase III trial to compare the effectiveness of methotrexate with that of dactinomycin in treating patients who have gestational trophoblastic neoplasia. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether methotrexate is more effective than dactinomycin in treating patients with gestational trophoblastic neoplasia.

Clinical Trial Conditions for Abitrexate

Condition Name

Condition Name for Abitrexate
Intervention	Trials
Untreated Adult Acute Lymphoblastic Leukemia	10
B Acute Lymphoblastic Leukemia	6
Untreated Childhood Acute Lymphoblastic Leukemia	6

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Abitrexate
Intervention	Trials
Leukemia	30
Leukemia, Lymphoid	26
Precursor Cell Lymphoblastic Leukemia-Lymphoma	26

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Abitrexate

Trials by Country

Trials by Country for Abitrexate
Location	Trials
United States	560
Canada	46
Australia	21
New Zealand	12
Japan	8

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Abitrexate
Location	Trials
Pennsylvania	21
Washington	21
Ohio	19
Texas	17
North Carolina	16

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Abitrexate

Clinical Trial Phase

Clinical Trial Phase for Abitrexate
Clinical Trial Phase	Trials
Phase 3	14
Phase 2/Phase 3	1
Phase 2	28

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Abitrexate
Clinical Trial Phase	Trials
Not yet recruiting	23
Recruiting	17
Completed	7

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Abitrexate

Sponsor Name

Sponsor Name for Abitrexate
Sponsor	Trials
National Cancer Institute (NCI)	47
Fred Hutchinson Cancer Research Center	9
M.D. Anderson Cancer Center	5

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Abitrexate
Sponsor	Trials
NIH	50
Other	35
Industry	4

Export unavailable in trial.
Subscribe for complete access.